Cancer Genetics (CG)

The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.

Cancer Genetics (CG) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Genetics, Molecular Biology, epigenetic, cytogenetic, and molecular changes in cancer cells, it also highlights the impact of genetic factors on cancer risk, diagnosis, treatment, Cancer Genetics supports evidence‑based progress in cancer diagnosis, personalized medicine, Cancer genetics, molecular oncology, cytogenetics, cancer genomics, molecular diagnostics , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2210-7762, E-ISSN: 1873-4456, Established: 2011, Impact Factor: 2.1
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE